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In this issue of Acta Orthopaedica, there are 2 papers deal-
ing with postoperative infections after joint arthroplasty. Ste-
fansdóttir et al. (2009) discuss the timing of the preoperative 
prophylactic antibiotics and Dale et al. (2009) report a pos-
sible increase in the infection rate for total hip arthroplasty in 
Norway. These papers give us reason to reflect on the ques-
tion of whether our efforts to prevent surgical site infections 
are sufficiently effective, and what percentage of infection we 
should try to achieve as a result of all our preventive mea-
sures.
A  deep  postoperative  infection  in  orthopedic  surgery 
involves bone and biomaterials, and is difficult to heal with-
out removal of the biomaterials. Although the infection rate of 
1–2% in clean orthopedic operations is low compared to other 
kinds of surgery, there is a constant need to maintain the best 
possible infection prevention. Now and then, there is an epi-
sode of outbreak of surgical site infections (SSIs), sometimes 
with infection rates of more than 4–5%. The causes of such 
disastrous periods mostly remain unclear, but often the result 
is that the preventive measures are tightened by the orthope-
dic surgeons, which often causes irritation and resistance from 
other workers in the hospital.
The necessarily authoritarian way of protocol control in a 
hospital is often violated. We have the same experience as 
Stefansdóttir et al. that hygiene standards seem to worsen. 
People have a tendency to do their work in the easiest and 
most convenient way, which may cause a regrettable relax-
ation of hygiene standards, as also mentioned by Hughes and 
Anderson (1999). 
Many preventive measures to reduce postoperative infec-
tions have been investigated. They are based on improvement 
of the resistance of the host to infection on the one hand (e.g. 
body temperature, glucose level, antibiotics, nutritional state), 
and reduction of peroperative contamination of the wound on 
the other (e.g. disinfection, clean clothing, ultraclean air). The 
low infection rate in arthroplasties nowadays makes it almost 
impossible  to  perform  further  randomized  trials  on  infec-
tion prevention. In the famous study by Lidwell et al. (1987), 
which investigated the usefulness of clean air as a prevention 
measure, more than 8,000 joint prostheses were needed. The 
Dutch randomized trial by Wymenga (1991) compared the 
deep infection rate between 1 dose versus 1 day (3 doses) of 
systemic cefuroxim prophylaxis in 2,651 total hip implanta-
tions. Even this number was not enough to achieve a statisti-
cally significant result (0.83% vs. 0.45%), although the trend 
was that the 1-dose regimen doubled the infection rate. With 
such low infection rates, prophylactic studies become so large 
that they can no longer be financed.
The lack of a high level of evidence from a randomized trial 
is not, however, proof of ineffectiveness: the absence of evi-
dence is not the evidence of absence. In national guidelines, 
the level of evidence should be given as has been done, for 
example, in the CDC guidelines (Mangram et al. 1999). Evi-
dence from experiments and also theories based on the under-
standing of the “route of infection” should also be taken into 
account. 
In the Netherlands, a quality improvement program run by 
the CBO (the Dutch Institute for Healthcare Improvement, 
Utrecht, the Netherlands) has been in existence for 15 years 
to reduce postoperative infections (CBO 2009). The method 
of the “plan-do-study-act” (PDSA) cycle was used to improve   
process parameters without measuring the SSI rates. Accepted 
preventive measures were subjected to such PDSA approaches, 
such as limited preoperative shaving with clippers of only the 
incision site, minimizing the number of door openings during 
operations (van Tiel et al. 2006), and also the infusion of the 
prophylactic antibiotic at the right time, as now discussed in 
the Swedish study by Stefansdóttir. The acceptance of these 
hygiene improvements in daily OP practice is slow and takes 
years, but there is a clear tendency. Whether or not this does 
indeed result in a lower surgical site infection rate is not yet 
known, and it has now been seriously called into question by 
the Norwegian register data.
Systemic antibiotics are the best documented—and also the 
most effective—prophylactic measure to reduce surgical site 
infections. The reduction rate is about 80% (AlBuhairan et al. 
2008). There is no doubt that the timing is crucial: antibiot-
ics must been given intravenously 15–45 min before incision 
(Manniën et al. 2006). The choice of antibiotic (narrow or 
broader spectrum) and the dose (1 dose vs. 1 day) is more 
controversial.  In  general,  the  1-day  regimen  is  better  in 
arthroplasty (Wymenga 1991, Engesaeter et al. 2006), and 1 630  Acta Orthopaedica 2009; 80 (6): 629–632
dose is only effective if the half life of the antibiotic is more 
then 12 hours (Gillespie and Walenkamp 2001). The disap-
pointing result in the paper from Sweden (Stefansdóttir et al. 
2009) that in almost 50% of the operations the timing was not 
correct, illustrates that there is an urgent need for an involved 
surgeon at each department who repeatedly checks whether 
the whole package of preventive measures is being applied 
and who motivates his or her colleagues to adhere to treatment 
protocols.
When working on infection prophylaxis, one must know 
what SSI rate has to be achieved. The infection rate is one of 
the most important of the many quality parameters that are 
used for operations. Increasingly, hospital managers are using 
these data to judge whether departments are underperforming 
and the data from the national arthroplasty registers can be 
used in the same way (Robertsson 2007).
In the Netherlands, the government Inspectorate of Health-
care has made it obligatory for surgical departments to orga-
nize a reliable infection registration of their operations, and 
this information is made publicly available. Today, however, 
insurance companies also ask about data from the infection 
and complication registrations, and they use these data in their 
decision on which orthopedics departments and hospitals are 
contracted to implant prostheses. However, isolated SSI data 
not related to patient mix may cause misjudgements and incor-
rect decisions.
The question remains as to what SSI rate is acceptable, and 
where we can find the best benchmark data. Several national 
surveillance programs for nosocomial infections exist, which 
gather  data  on  incidence  of  SSI.  In  the  Netherlands,  the 
national PREZIES surveillance program has been recording 
postoperative infections from all types of surgery since 1996. 
The database of 1999–2008 covers 203,359 operations with 
5,985 deep and superficial postoperative infections (2.9%). 
There are 52,133 total hip operations included, of which only 
29,876 were adequately followed with a surveillance after dis-
charge as advised (up to 1 year). The incidence of infection in 
these patients was 1.0% deep and 1.1% superficial (PREZIES 
National Surveillance Network for Hospital Infections 2009). 
In other countries, comparative incidence surveillance pro-
grams exist: Germany (NRZ-KISS), Belgium (NSIH), Eng-
land (NINSS), Austria (ANISS), France, the US (Woodhead 
et al. 2002), and Australia (VICNISS). Comparisons of results 
between countries have been published: between the Neth-
erlands  and  Germany  (Manniën  et  al.  2007),  and  between 
England and the USA (Leong et al. 2006). In many countries, 
about 50% of the data collected apply to orthopedic opera-
tions, reflecting the relatively high degree of interest of ortho-
pedic surgeons in infection surveillance.
Because  superficial  infections  are  difficult  to  distinguish 
from aseptic wound complications and are often treated by 
family doctors after discharge, their registration is not reliable 
and it is better to focus on deep infections only. Surveillance 
after discharge for up to 1 year, as suggested by the the CDC, 
is important (Mangram et al. 1999). This minimum follow-
up time at the outpatient clinic requires both involvement and 
organizational  abilities  on  the  part  of  orthopedic  surgeons 
(Walenkamp 2003).
In the several national incidence surveillance programs, there 
is no indication that the deep infection rate for total hip arthro-
plasty is increasing: for many years it has remained around 
1%. The Dutch data show a statistically significant decrease of 
60% (Manniën et al. 2008), as mentioned by Stefansdóttir. In 
this calculation, however, superficial and deep infections were 
pooled. If only the deep infections are considered in the Dutch 
PREZIES registration, there appears to have been no statisti-
cally significant change in the infection rate in 10 years (van 
Benthem and Manniën 2009)
 The question is whether arthroplasty registers can be used to 
analyze trends in postoperative infections. As with most other 
registers, the arthroplasty register in Norway gives informa-
tion mainly based on the registration of revisions with removal 
or exchange of the whole or a part of a prosthesis (Engesaeter 
et al. 2006, Helse-Bergen 2008, Kärrholm et al. 2008, Hooper 
et al. 2009). If a reoperation is necessary without removal or 
exchange, then it is not recorded. 
Early postoperative prosthesis infections should be treated 
in the first postoperative weeks. With a combination of aggres-
sive surgical debridement with the prosthesis in situ and high-
dose antibiotics, most infected prostheses can be saved, in total 
hips nowadays up to 70% (Crockarell et al. 1998, Guilieri et 
al. 2004, Trebse et al. 2005, Toms et al. 2006). These infected 
but retained prostheses, treated in situ without removal, are 
not recorded as infected in a register that is based on removal 
or exchange of prosthesis parts. Thus, an additional registra-
tion of such an early reoperation is necessary—as recently 
introduced in the Swedish and Finnish registers, for example.
In  the  Swedish  register,  the  reoperations  are  subdivided 
into 3 groups: (1) revision with replacement or extraction of 
implant components, (2) major reoperations without replace-
ment or removal, and (3) minor reoperations without replace-
ment or removal. In this register, the number of reoperations 
in 2006 and 2007 increased by 2.7%, and for deep infections 
the number increased by 6.6% (Kärrholm et al. 2008). The 
percentage of reoperations for infections within the first 2 
postoperative years nationwide in Sweden was 0.6%, with 
a range between the hospitals of 0.0–2.8%. These data do 
not, however, capture postoperative infections that were not 
treated  surgically.  If  these  would  have  been  included,  the 
total infection rate for total hips in Sweden would appear to 
approach the 1% level, as found in the surveillance programs 
mentioned.
It has been stated that reoperation within 2 years “reflects 
mainly early and serious complications such as deep infections 
and revision due to repeated dislocation” and “is a quicker 
quality indicator and is easier to use in clinical improvement 
work than 10-year survival, which is an important but slow 
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The  Finnish  Knee  Arthroplasty  Register  (FAR)  met  the 
same problem in their study of knee prosthesis infections in 
the past few years. Jämsen et al. (2009) reviewed 38,676 knee 
prosthesis operations but they used not only revisions but also 
reoperations as endpoint. Because they supposed that many 
infection-related operations such as debridement, amputation, 
and arthrodesis were infrequently reported to the FAR, they 
collected parallel information from the Finnish Hospital Dis-
charge Register (HDR), which gives better information based 
on diagnoses. Comparison of the 2 databases gave informa-
tion about the reoperated infected prostheses, but not about 
the infections that were only treated with systemic antibiotics. 
These authors confirmed that the Finnish register underesti-
mates the infection rate.
In conclusion, there are 3 levels of registration available 
in large databases with an increasing degree of reliability: 
firstly, registrations of revisions for infection with component 
removal or exchange, then reoperations for infection but with 
retention of the prosthesis, and finally surveillance programs 
on incidence of surgical site infection in departments, hospi-
tals, or countries. These combined data should be used for reli-
able estimation of the true infection rate.
The  report  from  the  Norwegian  register  of  a  probable 
increase in the percentage of total hip prostheses that had to 
be removed because of infection is interesting, but the reason 
for the increase is unclear. The authors’ analysis is relevant, 
but I would like to add the possibility that the increase in more 
resistant germs such as MRSE and MRSA, and the technically 
more complex reconstructions have resulted in infections that 
are more difficult to treat. So the question remains whether the 
infection rate in total hips increases. 
In 2001, Lidgren, co-author of the paper by Stefansdótter et 
al., wrote a guest editorial in this journal on the same subject 
with the optimistic title: “Joint prosthetic infections: a success 
story” (Lidgren 2001). They now suggest in their own arti-
cle that this statement is no longer true, and that the problem 
remains as before.
There is an indication that prophylactic hygiene standards 
in hospitals should be improved. There is also a need for more 
exact data on infection rates, perhaps by a smart combination 
of data provided by the increasing number of arthroplasty reg-
isters and by national SSI surveillance programs. We must not 
be satisfied with a deep infection rate of more then 1% for 
clean orthopedic operations, and we must be able to prove that 
relatively low infection rate using reliable surveillance.
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